Y.D. More Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Y.D. More Investments’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-89	Closed	-$8.11K	–	532
2025 Q3	$8.11K	Buy	89 +69	+345%	+$28.8K	﹤0.01%	379
2025 Q2	$8.9K	Hold	20	–	–	﹤0.01%	382
2025 Q1	$9.7K	Hold	20	–	–	﹤0.01%	384
2024 Q4	$8.05K	Hold	20	–	–	﹤0.01%	380
2024 Q3	$9.3K	Hold	20	–	–	﹤0.01%	362
2024 Q2	$9.37K	Hold	20	–	–	﹤0.01%	370
2024 Q1	$8.36K	Hold	20	–	–	﹤0.01%	315
2023 Q4	$8.14K	Hold	20	–	–	﹤0.01%	328
2023 Q3	$6.96K	Sell	20 -20	-50%	-$7K	﹤0.01%	317
2023 Q2	$14.1K	Sell	40 -35	-47%	-$11.8K	﹤0.01%	277
2023 Q1	$23.6K	Sell	75 -15	-17%	-$4.5K	0.01%	264
2022 Q4	$26K	Buy	+90	New	+$27.4K	0.01%	297

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Y.D. More Investments's VRTX Position: Q4 2025 in Review

Y.D. More Investments sold out of Vertex Pharmaceuticals (VRTX) in Q4 2025, closing a stake of 89 shares — an estimated $8.11K sold.

Y.D. More Investments first reported a position in VRTX in Q4 2022 and held it in 12 quarters. The position peaked at $26K in Q4 2022. 1,674 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.

Y.D. More Investments reported no remaining Vertex Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Y.D. More Investments sold 89 Vertex Pharmaceuticals shares in Q4 2025, an estimated $8.11K.
Y.D. More Investments first reported a position in Vertex Pharmaceuticals in Q4 2022 and held it in 12 quarters.
Y.D. More Investments's Vertex Pharmaceuticals position peaked at $26K in Q4 2022.
1,674 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.

Based on Y.D. More Investments's 13F filing for Q4 2025, filed 21 Jan 2026.